Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

50° Sunny
- Saint Marys, OH (45885)
  Today
  
  A clear sky. Low 26F. WNW winds at 10 to 20 mph, decreasing to less than 5 mph..
  
  Tonight
  
  A clear sky. Low 26F. WNW winds at 10 to 20 mph, decreasing to less than 5 mph.
  
  Updated: November 16, 2025 @ 3:04 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

232.36 +0.07 (+0.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

89 90 Next >

Top S&P500 movers in Friday's session ↗

January 31, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday? ↗

January 31, 2025

Major stock indices have completed their recovery following Monday's sharp drop, buoyed by tech stocks rallying on the back of solid earnings and positive macroeconomic data. The S&P 500 index stands...

Via Benzinga

Topics Stocks

Why AbbVie Stock Is Jumping Today ↗

January 31, 2025

Via The Motley Fool

$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today ↗

January 30, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts ↗

January 28, 2025

Via Benzinga

$1000 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today ↗

January 24, 2025

Via Benzinga

AbbVie Investors Trigger Trend-Following Signal: Time to Load Up

January 31, 2025

AbbVie is on track to sustain growth in the wake of Humira's patent cliff and the forecasts are too low. Investors can look forward to an upgrade cycle in 2025.

Via MarketBeat

Topics Intellectual Property

AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens ↗

January 31, 2025

The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025.

Via Stocktwits

Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday ↗

January 31, 2025

Via Benzinga

AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline ↗

January 31, 2025

AbbVie Q4 earnings beat estimates, driven by strong sales of Skyrizi and Rinvoq, with an updated 2027 combined revenue forecast of $31 billion for both drugs.

Via Benzinga

Topics Earnings

Unpacking the Latest Options Trading Trends in AbbVie ↗

January 24, 2025

Via Benzinga

5 Top Stocks to Buy in February 2025 ↗

January 31, 2025

All of them have great upside.

Via The Motley Fool

Friday's pre-market session: top gainers and losers in the S&P500 index ↗

January 31, 2025

Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.

Via Chartmill

AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate ↗

January 31, 2025

The company now expects Skyrizi and Rinvoq to bring in $31 billion in combined sales in 2027.

Via Investor's Business Daily

US Stock Futures Climb After Apple Beats Q4 Expectations: Expert Says Tech Stocks Hold Above Key Level Despite DeepSeek Impact ↗

January 31, 2025

US stock futures climbed on Friday, pointing to a third straight week of gains fueled by strong corporate earnings.

Via Benzinga

Earnings Scheduled For January 31, 2025 ↗

January 31, 2025

Via Benzinga

AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings? ↗

January 30, 2025

AbbVie and Novartis to report Q4 earnings. AbbVie in stagnating trend, Novartis bullish. Breakdown of technical charts. Novartis has advantage, investors watch for post-earnings movement.

Via Benzinga

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders ↗

January 29, 2025

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Via Benzinga

Topics Government

I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One. ↗

January 28, 2025

Via The Motley Fool

Why AbbVie Stock Popped While the Market Flopped on Monday ↗

January 27, 2025

Via The Motley Fool

AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive ↗

January 27, 2025

AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth remains a key focus for investors.

Via Benzinga

Biotech And Healthcare Stocks Poised For Gains Ahead ↗

January 27, 2025

The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech.

Via Talk Markets

Topics ETFs Stocks / Equities

Is AbbVie Stock a Buy? ↗

January 24, 2025

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

Via The Motley Fool

Topics Intellectual Property

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever ↗

January 21, 2025

Via The Motley Fool

Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why ↗

January 21, 2025

The company expects to soon expand from a single-product player to a "multi-product innovator."

Via Investor's Business Daily

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever ↗

January 21, 2025

Via The Motley Fool

3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever ↗

January 21, 2025

Via The Motley Fool

Healthcare And Biotech Stocks Lag The Market Again ↗

January 20, 2025

Biotech stocks got little help from the JPM Conference despite some recovery to the general market.

Via Talk Markets

Topics Stocks / Equities

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt ↗

January 17, 2025

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.

Via Benzinga

Topics Government

January 17, 2025

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New prices aim to save billions by 2027.

Via Benzinga

Topics Economy

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Business
Announcements
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Evening Leader

theeveningleader.com
102 E. Spring St.
Saint Marys, Ohio 45885
Phone: 419-394-7414
Email: editor@theeveningleader.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Saint Marys, OH (45885)

Today

Tonight

AbbVie (NY:ABBV)

All News about AbbVie

Sections

Services

The Evening Leader